Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation

Transplant International

Volumn 22, Issue 6, 2009, Pages 635-643

  Neurohr, Claus ^a   Huppmann, Patrick ^a   Zimmermann, Gregor ^a   Leuchte, Hanno ^a   Baumgartner, Rainer ^a   Hatz, Rudolf ^a   Frey, Lorenz ^a   Überfuhr, Peter ^a   Bittmann, Iris ^b   Behr, Jürgen ^a   Reichart, Bruno ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Lung transplantation; Mycophenolate mofetil; Survival; Tacrolimus

Indexed keywords

ACICLOVIR; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CACHEXIA; DIARRHEA; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; LEUKOPENIA; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

BRONCHIOLITIS OBLITERANS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; SURVIVAL ANALYSIS; TACROLIMUS;

EID: 65549163983     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00843.x     Document Type: Article

References (31)

1. Orens JB, Estenne M, Arcasoy S, et al., Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 25 : 745. (Pubitemid 43963375)
2. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 26 : 782. (Pubitemid 47199080)
3. Knoop C, Haverich A, Fischer S. Immunosuppressive therapy after human lung transplantation. Eur Respir J 2004 23 : 159. (Pubitemid 38088513)
4. Knoop C, Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med 2006 27 : 521. (Pubitemid 44672555)
5. Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995 60 : 580.
6. Hachem RR, Yusen RD, Chakinala MM, et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007 26 : 1012. (Pubitemid 47494659)
7. Lama R, Santos F, Algar FJ, Alvarez A, Baamonde C. Lung transplants with tacrolimus and mycophenolate mofetil: a review. Transplant Proc 2003 35 : 1968. (Pubitemid 37093782)
8. Bhorade SM, Jordan A, Villanueva J, et al. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant 2003 3 : 1570. (Pubitemid 37541515)
9. Palmer SM, Baz MA, Sanders L, et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. Transplantation 2001 71 : 1772. (Pubitemid 32622489)
10. Zuckermann A, Reichenspurner H, Birsan T, et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 2003 125 : 891. (Pubitemid 36457511)
11. Treede H, Klepetko W, Reichenspurner H, et al. Munich and Vienna Lung Transplant Group. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 2001 20 : 511. (Pubitemid 32410012)
12. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996 15 (1 Pt 1 1. (Pubitemid 26056119)
13. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297. (Pubitemid 34224094)
14. Ding IB, Baumgartner RA, Schwaiblmair M, Behr J. Administration of anti-interleukin-2 Ralpha monoclonal antibody in bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2003 75 : 1767. (Pubitemid 36629172)
15. de Perrot M, Chaparro C, McRae K, et al. Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004 127 : 1493. (Pubitemid 38560618)
16. Moffatt SD, Demers P, Robbins RC, et al. Lung transplantation: a decade of experience. J Heart Lung Transplant 2005 24 : 145. (Pubitemid 40215588)
17. Burton CM, Milman N, Carlsen J, et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 2005 24 : 1834. (Pubitemid 41641860)
18. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007 26 : 681. (Pubitemid 47001706)
19. McNeil K, Glanville AR, Wahlers T, et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation 2006 81 : 998. (Pubitemid 43670432)
20. Izbicki G, Shitrit D, Aravot D, et al. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. Transplant Proc 2002 34 : 3258. (Pubitemid 35463312)
21. Reichenspurner H, Kur F, Treede H, et al. Optimization of the immunosuppressive protocol after lung transplantation. Transplantation 1999 68 : 67. (Pubitemid 29352832)
22. Reichenspurner H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J Heart Lung Transplant 2005 24 : 119. (Pubitemid 40215585)
23. Zuckermann A, Reichenspurner H, Jaksch J, et al. Long term follow-up of a prospective randomized trial comparing tacrolimus versus cyclosporine in combination with MMF after lung transplantation. J Heart Lung Transplant 2003 22 : S76.
24. Reichenspurner H, Glanville A, Klepetko W, et al. Prospective randomized international multi-center investigator driven study comparing TAC and CSA (+MMF/steroids) after lung transplantation - interim analysis of 110 patients. J Heart Lung Transplant 2003 22 : S77.
25. Vincenti F, Friman S, Scheuermann E, et al., DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007 7 : 1506. (Pubitemid 46776239)
26. Stelzmueller I, Lass-Floerl C, Geltner C, et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int 2008 21 : 534.
27. Jiménez C, Manrique A, Marqués E, et al. Incidence and risk factors for the development of lung tumors after liver transplantation. Transpl Int 2007 20 : 57.
28. Worel N, Bojic A, Binder M, et al. Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysis. Transpl Int 2008 21 : 1098.
29. Neurohr C, Huppmann P, Leuchte H, et al., Munich Lung Transplant Group. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?. Am J Transplant 2005 5 : 2982. (Pubitemid 43923961)
30. Speich R, Nicod LP, Aubert JD, et al. Ten years of lung transplantation in Switzerland: results of the Swiss Lung Transplant Registry. Swiss Med Wkly 2004 134 : 18. (Pubitemid 38113603)
31. McShane PJ, Garrity Jr. ER. Minimization of immunosuppression after lung transplantation: current trends. Transpl Int 2009 1 : 22 (1 Special Review Issue).